THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 152 filers reported holding THERAPEUTICSMD INC in Q1 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,031,000 | +6.9% | 5,344,302 | 0.0% | 0.07% | -18.9% |
| Q4 2021 | $1,900,000 | -52.0% | 5,344,302 | 0.0% | 0.09% | -18.9% |
| Q3 2021 | $3,962,000 | +18.5% | 5,344,302 | +90.2% | 0.11% | -47.1% |
| Q2 2021 | $3,343,000 | -10.7% | 2,809,702 | +0.6% | 0.21% | -4.1% |
| Q1 2021 | $3,744,000 | -31.6% | 2,794,302 | -38.2% | 0.22% | -45.5% |
| Q4 2020 | $5,470,000 | -75.2% | 4,520,610 | -67.6% | 0.40% | -80.4% |
| Q3 2020 | $22,013,000 | +89.7% | 13,932,542 | +50.0% | 2.05% | +53.8% |
| Q2 2020 | $11,607,000 | +13.9% | 9,285,274 | -3.4% | 1.34% | -17.0% |
| Q1 2020 | $10,189,000 | -61.8% | 9,611,828 | -12.7% | 1.61% | -46.6% |
| Q4 2019 | $26,652,000 | +6.7% | 11,013,187 | +60.1% | 3.01% | +31.5% |
| Q3 2019 | $24,976,000 | +42.5% | 6,880,540 | +2.0% | 2.29% | +65.8% |
| Q2 2019 | $17,531,000 | -23.3% | 6,742,538 | +43.7% | 1.38% | -35.3% |
| Q1 2019 | $22,845,000 | +288.1% | 4,690,970 | +203.6% | 2.13% | +192.6% |
| Q4 2018 | $5,887,000 | – | 1,545,228 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 3,560,816 | $2,641,000 | 0.48% |
| Rubric Capital Management LP | 5,344,302 | $3,962,000 | 0.11% |
| Birchview Capital, LP | 100,000 | $74,000 | 0.05% |
| C WorldWide Group Holding A/S | 6,189,834 | $4,589,000 | 0.05% |
| MCDONALD PARTNERS LLC | 226,000 | $168,000 | 0.04% |
| Traynor Capital Management, Inc. | 367,991 | $272,000 | 0.04% |
| Platform Technology Partners | 100,000 | $74,000 | 0.03% |
| EMFO, LLC | 44,500 | $33,000 | 0.03% |
| Knights of Columbus Asset Advisors LLC | 365,105 | $271,000 | 0.02% |
| Kowal Investment Group, LLC | 98,631 | $73,000 | 0.02% |